Phesgo 1,200-600MG-30,000 unit 15ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT4ZP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,673
Award facts
- Contract value 100% obligated
- $34,672.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase-oysk), a therapeutic monoclonal antibody combination used in oncology treatment. The order specifies 30,000 units of 15mL vials at a ceiling value of $34,672.80 with a firm fixed price contract type and an ultimate completion date of January 22, 2026. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its role in supplying branded and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order exemplifies the company's ongoing support to the Defense Health Agency and other government healthcare entities through flexible contract vehicles that enable rapid procurement of essential pharmaceutical products to support military readiness and healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FT4ZP?
SPE2DR26FT4ZP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FT4ZP worth?
The government has obligated $34,673 on SPE2DR26FT4ZP.
Is contract SPE2DR26FT4ZP an order under another contract?
Yes. SPE2DR26FT4ZP is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT4ZP competed?
The extent of competition for SPE2DR26FT4ZP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award